Harmony Lifescience Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 06-12-2024
- Paid Up Capital ₹ 0.10 M
as on 06-12-2024
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 12.50 Cr
as on 06-12-2024
- Revenue -3.07%
(FY 2022)
- Profit -45.96%
(FY 2022)
- Ebitda -27.16%
(FY 2022)
- Net Worth 10.68%
(FY 2022)
- Total Assets 14.97%
(FY 2022)
About Harmony Lifescience
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹12.50 Cr.
Abhijeet Kumar, Vedant Kulkarni, and Pundalik Kadam serve as directors at the Company.
- CIN/LLPIN
U24233MH2016PTC273678
- Company No.
273678
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Mar 2016
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationMumbai, Maharashtra
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Harmony Lifescience?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhijeet Kumar  | Whole-Time Director | 27-Jul-2017 | Current |
| Vedant Kulkarni | Director | 01-Sep-2021 | Current |
| Pundalik Kadam | Director | 25-Oct-2023 | Current |
Financial Performance of Harmony Lifescience.
Harmony Lifescience Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 3.07% decrease. The company also saw a substantial fall in profitability, with a 45.96% decrease in profit. The company's net worth Soared by an impressive increase of 10.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Harmony Lifescience?
In 2022, Harmony Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Armonia Life Science Private LimitedActive 20 years 10 monthsAbhijeet Kumar, Vedant Kulkarni and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
New India Co-Op Bank Limited Creation Date: 23 Mar 2016 | ₹12.50 Cr | Open |
How Many Employees Work at Harmony Lifescience?
Harmony Lifescience has a workforce of 4 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Harmony Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Harmony Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
